Human Growth Hormone (hGH) Market Status and Trend Analysis 2017-2026 (COVID-19 Version) | Analytical Research Cognizance

Human Growth Hormone (hGH) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Published by ARCNS001
Report ID 1514072
Published date Nov 24, 2020
Category Pharmaceuticals and Healthcare
Total Pages 96
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Human Growth Hormone (hGH) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Human Growth Hormone (hGH) market segmented into
Recombinant Human Growth Hormone (rhGH)
Human Growth Hormone (rhGH)

Based on the end-use, the global Human Growth Hormone (hGH) market classified into
Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Small for Gestational Age
Others

Based on geography, the global Human Growth Hormone (hGH) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Eli Lilly and Company
Ferring Holding SA
Genentech
Merck & Co.
Novo Nordisk
Pfizer
Sandoz International GmbH
Ipsen

Chapter One: RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HUMAN GROWTH HORMONE (HGH) INDUSTRY
2.1 Summary about Human Growth Hormone (hGH) Industry
2.2 Human Growth Hormone (hGH) Market Trends
2.2.1 Human Growth Hormone (hGH) Production & Consumption Trends
2.2.2 Human Growth Hormone (hGH) Demand Structure Trends
2.3 Human Growth Hormone (hGH) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant Human Growth Hormone (rhGH)
4.2.2 Human Growth Hormone (rhGH)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Growth Hormone Deficiency
4.3.2 Turner Syndrome
4.3.3 Idiopathic Short Stature
4.3.4 Prader-Willi Syndrome
4.3.5 Small for Gestational Age
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant Human Growth Hormone (rhGH)
5.2.2 Human Growth Hormone (rhGH)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Growth Hormone Deficiency
5.3.2 Turner Syndrome
5.3.3 Idiopathic Short Stature
5.3.4 Prader-Willi Syndrome
5.3.5 Small for Gestational Age
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant Human Growth Hormone (rhGH)
6.2.2 Human Growth Hormone (rhGH)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Growth Hormone Deficiency
6.3.2 Turner Syndrome
6.3.3 Idiopathic Short Stature
6.3.4 Prader-Willi Syndrome
6.3.5 Small for Gestational Age
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant Human Growth Hormone (rhGH)
7.2.2 Human Growth Hormone (rhGH)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Growth Hormone Deficiency
7.3.2 Turner Syndrome
7.3.3 Idiopathic Short Stature
7.3.4 Prader-Willi Syndrome
7.3.5 Small for Gestational Age
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant Human Growth Hormone (rhGH)
8.2.2 Human Growth Hormone (rhGH)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Growth Hormone Deficiency
8.3.2 Turner Syndrome
8.3.3 Idiopathic Short Stature
8.3.4 Prader-Willi Syndrome
8.3.5 Small for Gestational Age
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant Human Growth Hormone (rhGH)
9.2.2 Human Growth Hormone (rhGH)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Growth Hormone Deficiency
9.3.2 Turner Syndrome
9.3.3 Idiopathic Short Stature
9.3.4 Prader-Willi Syndrome
9.3.5 Small for Gestational Age
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Eli Lilly and Company
10.1.2 Ferring Holding SA
10.1.3 Genentech
10.1.4 Merck & Co.
10.1.5 Novo Nordisk
10.1.6 Pfizer
10.1.7 Sandoz International GmbH
10.1.8 Ipsen
10.2 Human Growth Hormone (hGH) Sales Date of Major Players (2017-2020e)
10.2.1 Eli Lilly and Company
10.2.2 Ferring Holding SA
10.2.3 Genentech
10.2.4 Merck & Co.
10.2.5 Novo Nordisk
10.2.6 Pfizer
10.2.7 Sandoz International GmbH
10.2.8 Ipsen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Human Growth Hormone (hGH) Product Type Overview
2.Table Human Growth Hormone (hGH) Product Type Market Share List
3.Table Human Growth Hormone (hGH) Product Type of Major Players
4.Table Brief Introduction of Eli Lilly and Company
5.Table Brief Introduction of Ferring Holding SA
6.Table Brief Introduction of Genentech
7.Table Brief Introduction of Merck & Co.
8.Table Brief Introduction of Novo Nordisk
9.Table Brief Introduction of Pfizer
10.Table Brief Introduction of Sandoz International GmbH
11.Table Brief Introduction of Ipsen
12.Table Products & Services of Eli Lilly and Company
13.Table Products & Services of Ferring Holding SA
14.Table Products & Services of Genentech
15.Table Products & Services of Merck & Co.
16.Table Products & Services of Novo Nordisk
17.Table Products & Services of Pfizer
18.Table Products & Services of Sandoz International GmbH
19.Table Products & Services of Ipsen
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Human Growth Hormone (hGH) Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Human Growth Hormone (hGH) Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Human Growth Hormone (hGH) Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Human Growth Hormone (hGH) Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Human Growth Hormone (hGH) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Human Growth Hormone (hGH) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Human Growth Hormone (hGH) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Human Growth Hormone (hGH) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Human Growth Hormone (hGH) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Human Growth Hormone (hGH) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Human Growth Hormone (hGH) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Recombinant Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Growth Hormone Deficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Turner Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Idiopathic Short Stature Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Prader-Willi Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Small for Gestational Age Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Recombinant Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Growth Hormone Deficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Turner Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Idiopathic Short Stature Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Prader-Willi Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Small for Gestational Age Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Recombinant Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Growth Hormone Deficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Turner Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Idiopathic Short Stature Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Prader-Willi Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Small for Gestational Age Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Recombinant Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Growth Hormone Deficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Turner Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Idiopathic Short Stature Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Prader-Willi Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Small for Gestational Age Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Recombinant Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Human Growth Hormone (rhGH) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Growth Hormone Deficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Turner Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Idiopathic Short Stature Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Prader-Willi Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Small for Gestational Age Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (